Shinagawa, Japan

Seigo Ueda


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 155(Granted Patents)


Location History:

  • Hiromachi, JP (1978)
  • Tokyo, JP (1988)
  • Shinagawa, JP (1991)

Company Filing History:


Years Active: 1978-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seigo Ueda: Innovator in Pharmaceutical Formulations

Introduction

Seigo Ueda is a notable inventor based in Shinagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 3 patents to his name, Ueda's work has the potential to impact the medical industry positively.

Latest Patents

Ueda's latest patents include a method of preparing a freeze-dried formulation containing a drug. This innovative freeze-drying method involves freezing a first liquid, adding a second liquid to the frozen first liquid, and then freeze-drying both together. This process allows for the pharmaceutical compound to be effectively preserved. Another significant patent focuses on a composition containing a penem or carbapenem antibiotic. This invention addresses renal issues associated with antibiotic administration by incorporating an N-acylated amino acid, which can be formulated together with the antibiotic or administered separately.

Career Highlights

Seigo Ueda is currently associated with Sankyo Company, Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving pharmaceutical formulations and enhancing patient outcomes.

Collaborations

Ueda collaborates with esteemed colleagues such as Takashi Shiokari and Masayuki Iwata. Their combined expertise contributes to the innovative projects undertaken at Sankyo Company, Limited.

Conclusion

Seigo Ueda's contributions to pharmaceutical innovations demonstrate his dedication to improving drug formulations and patient care. His patents reflect a deep understanding of the complexities involved in pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…